Twist Bioscience Corp (TWST)
28.33
-0.24
(-0.84%)
USD |
NASDAQ |
Apr 18, 16:00
28.38
+0.05
(+0.18%)
After-Hours: 20:00
Twist Bioscience Cash from Financing (TTM): -0.167M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.167M |
September 30, 2023 | 0.911M |
June 30, 2023 | 1.709M |
March 31, 2023 | 1.059M |
December 31, 2022 | 271.15M |
September 30, 2022 | 270.53M |
June 30, 2022 | 270.87M |
March 31, 2022 | 271.42M |
December 31, 2021 | 1.25M |
September 30, 2021 | 329.18M |
June 30, 2021 | 333.18M |
Date | Value |
---|---|
March 31, 2021 | 442.01M |
December 31, 2020 | 628.60M |
September 30, 2020 | 303.73M |
June 30, 2020 | 301.09M |
March 31, 2020 | 277.31M |
December 31, 2019 | 87.64M |
September 30, 2019 | 158.58M |
June 30, 2019 | 162.23M |
March 31, 2019 | 102.78M |
December 31, 2018 | 159.16M |
September 30, 2018 | 88.82M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.167M
Minimum
Dec 2023
628.60M
Maximum
Dec 2020
216.44M
Average
270.87M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Retractable Technologies Inc | 0.9416M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |